Advertisement

Clinical and Molecular Neurogenetics in Neurosurgery

  • A. E. Harding
Part of the Advances and Technical Standards in Neurosurgery book series (NEUROSURGERY, volume 20)

Summary

This chapter describes the basic principles of molecular genetics, particularly in relation to gene mapping and isolation (positional cloning). The application of this technology is illustrated by progress in elucidating the molecular basis of inherited tumour syndromes, including neurofibromatosis types 1 and 2 and von Hippel-Lindau disease, and molecular studies of tumourigenesis in malignant gliomas.

Keywords

Acoustic Neuroma Nerve Growth Factor Receptor Plexiform Neurofibroma Lisch Nodule Retinal Angioma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD (eds) (1989) Molecular biology of the cell, 2nd Ed. Garland, New YorkGoogle Scholar
  2. 2.
    Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, Van Tuinen SR, Ledbetter DH, Barker DF, Nakamura Y, White R, Vogelstein B (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217–220PubMedCrossRefGoogle Scholar
  3. 3.
    Barker D, Wright E, Nguyen K, Cannon L, Fain P, Goldgar D, Bishop DT, Carey J, Baty B, Kivlin J, Willard H, Waye JS, Greig G, Leinwand L, Nakamura Y, O’Connell P, Leppert M, Lalouel J-M, White R, Skolnick M (1987) Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 236: 1100–1102PubMedCrossRefGoogle Scholar
  4. 4.
    Bird AP (1987) CpG islands as gene markers in the vertebrate nucleus. Trends Genet 36: 342–346CrossRefGoogle Scholar
  5. 5.
    Boughey AM, Fletcher NA, Harding AE (1990) Central nervous system haemangioblastoma: a clinical and genetic study of 52 cases. J Neurol Neurosurg Psychiatry 53: 644–648PubMedCrossRefGoogle Scholar
  6. 6.
    Burke DT, Carle GF, Olson MV (1987) Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors. Science 236: 806–812PubMedCrossRefGoogle Scholar
  7. 7.
    Cawthon RM, Weiss R, Xu G, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O’Connell P, White R (1990) A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62: 193–201PubMedCrossRefGoogle Scholar
  8. 8.
    Collins FS (1988) Chromosome jumping. In: Davies KE (ed) Genome analysis: a practical approach. IRL Press, Oxford, pp 73–94Google Scholar
  9. 9.
    Collins FS, O’Connell P, Ponder BAJ, Seizinger BR (1989) Progress towards identifying the neurofibromatosis (NF 1) gene. Trends Genet 5: 217–221PubMedCrossRefGoogle Scholar
  10. 10.
    Crowe FW, Schull WJ, Neel JV (1956) A clinical, pathological and genetic study of multiple neurofibromatosis. Thomas, Springfield, Illinois, p 153Google Scholar
  11. 11.
    Davies KE, Read AP (1988) Molecular basis of inherited disease. IRL Press, OxfordGoogle Scholar
  12. 12.
    Eisenstein BI (1990) The polymerase chain reaction. A new method of using molecular genetics for medical diagnosis. N Engl J Med 322: 178–183PubMedCrossRefGoogle Scholar
  13. 13.
    Fain PR, Goldgar DE, Wallace MR, Collins FS, Wright E, Nguyen K, Barker DF (1989) Refined physical and genetic mapping of the NF 1 region on chromosome 17. Am J Hum Genet 45: 721–728PubMedGoogle Scholar
  14. 14.
    Feinberg AP, Vogelstein B (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6–13PubMedCrossRefGoogle Scholar
  15. 15.
    Fults D, Tippets RH, Thomas GA, Nakamura Y, White R (1989) Loss of heterozygosity for loci on chromosome 17 p in human malignant astrocytoma. Cancer Res 49: 6572–6576PubMedGoogle Scholar
  16. 16.
    Go RCP, Lamiell JM, Hsia YE, Yuen JWM, Paik Y (1984) Segregation and linkage analyses of von Hippel-Lindau disease among 220 descendants from one kindred. Am J Hum Genet 36: 131–142PubMedGoogle Scholar
  17. 17.
    Hsiao K, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250: 1587–1590PubMedCrossRefGoogle Scholar
  18. 18.
    Hughes GB, Sismanis A, Glasscock ME, Wilson LK (1982) Audiological manifestations in bilateral acoustic tumours. Laryngoscope 92: 1351–1359PubMedCrossRefGoogle Scholar
  19. 19.
    Huson SM, Thrush DC (1985) Central neurofibromatosis. Quart J Med 218: 213–224Google Scholar
  20. 20.
    Huson SM, Harper PS, Hourihan MD, Cole G, Weeks RD, Compston DAS (1986) Cerebellar haemangioblastoma and von Hippel-Lindau disease. Brain 109: 1297–1310PubMedCrossRefGoogle Scholar
  21. 21.
    Huson SM, Harper P, Compston DAS (1988) Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales. Brain 111: 1355–1381PubMedCrossRefGoogle Scholar
  22. 22.
    Illgren EB, Kinnier-Wilson LM, Stiller CA (1985) Gliomas in neurofibromatosis: a series of 89 cases with evidence for enhanced malignancy in associated cerebellar astrocytomas. Path Annual 20: 331–358Google Scholar
  23. 23.
    James CD, Carlbom E, Dumanski JP, Hausen M, Nordensjold M, Collins VP, Cavenee WK (1988) Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546–5551PubMedGoogle Scholar
  24. 24.
    James CD, Carlbom E, Nordenskjold M, Collins VP, Cavenee WK (1989) Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci USA 86: 2858–2862PubMedCrossRefGoogle Scholar
  25. 25.
    Jennings AM, Smith C, Cole DR, Jennings C, Shortland JR, Williams JL, Brown CB (1988) Von Hippel-Lindau disease in a large British family: clin-icopathological features and recommendations for screening and follow-up. QJ Med 66: 233–250Google Scholar
  26. 26.
    Kanter WR, Eldridge R, Fabricant R, Allen JC, Koerber T (1980) Central neurofibromatosis with bilateral acoustic neuroma: genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology 30: 851–859PubMedGoogle Scholar
  27. 27.
    Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820–823PubMedCrossRefGoogle Scholar
  28. 28.
    Lubs M-L E, Bauer MS, Formas ME, Djokic B (1991) Lisch nodules in neurofibromatosis type I. N Engl J Med 324: 1264–1266PubMedCrossRefGoogle Scholar
  29. 29.
    Maher ER, Yates JRW, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA (1990) Clinical features and natural history of von HippelLindau disease. QJ Med 77: 1151–1164Google Scholar
  30. 30.
    Maher ER, Bentley E, Yates JRW, Latif F, Lerman M, Zbar B, Affara NA, Ferguson-Smith MA (1991) Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3 p by genetic linkage analysis. Genomics 10: 957–960PubMedCrossRefGoogle Scholar
  31. 31.
    Maher ER, Hosoe S, Bentley E, Latif F, Yates JRW, Linehan M, Payne S, Barton D, Glenn G, Affara NA, Lerman M, Zbar B, Ferguson-Smith MA (1992) Modification of risk in von Hippel-Lindau disease with flanking DNA markers. J Med Genet 29: 274Google Scholar
  32. 32.
    Martuza RL, Eldrige R (1988) Neurofibromatosis 2 ( Bilateral acoustic neurofibromatosis ). N Engl J Med 318: 684–688PubMedCrossRefGoogle Scholar
  33. 33.
    Menon AG, Anderson KM, Riccardi VM, Chung RY, Whaley JM, Yandell DW, Farmer GE, Freiman RN, Lee JK, Li FP, Barker DF, Ledbetter DH, Kleider A, Martuza RL, Gusella JF, Seizinger BR (1990) Chromosome 17 p deletions and p53 mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 87: 5435–5349PubMedCrossRefGoogle Scholar
  34. 34.
    Miller RM, Sparkes RS (1977) Segmental neurofibromatosis. Arch Dermatol 113: 837–838PubMedCrossRefGoogle Scholar
  35. 35.
    Nakamura Y, Leppert M, O’Connell P, Wolff R, Holm T, Culver M, Martin C, Fujimoto E, Hoff M, Kumlin E, White R (1987) Variable number of tandem repeat ( VNTR) markers for human gene mapping. Science 23: 1616–1622CrossRefGoogle Scholar
  36. 36.
    Neumann HPH, Wiestler OD (1991) Clustering of features of von HippelLindau syndrome: evidence for a complex genetic locus. Lancet 337: 1052–1054PubMedCrossRefGoogle Scholar
  37. 37.
    Nigro JM, Baker SJ, Preisinger AC, Milburn Jessup J, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B (1989) Mutations in the p 53 gene occur in diverse human tumour types. Nature 342: 705–708PubMedCrossRefGoogle Scholar
  38. 38.
    Noll WW, Collins M (1987) Detection of human DNA polymorphisms with a simplified denaturing gradient gel electrophoresis technique. Proc Natl Acad Sci USA 84: 3339–3343PubMedCrossRefGoogle Scholar
  39. 39.
    Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874–879PubMedCrossRefGoogle Scholar
  40. 40.
    Ott J (1986) A short guide to linkage analysis. In: Davies KE (ed) Human genetic diseases: a practical approach. IRL Press, Oxford, pp 19–32Google Scholar
  41. 41.
    Payne SJ, Maher ER, Barton DE, Bentley E, McMahon R, Quarrell OWJ, Ferguson-Smith MA (1992) Prenatal diagnosis in von Hippel-Lindau disease. J Med Genet 29: 282–283Google Scholar
  42. 42.
    Riccardi VM (1980) The pathophysiology of neurofibromatosis: dermatologic insights into heterogeneity and pathogenesis. J Am Acad Dermatol 3: 157–163PubMedCrossRefGoogle Scholar
  43. 43.
    Riccardi VM (1982) Neurofibromatosis: clinical heterogeneity. Curr Prob Cancer VII: 1–24CrossRefGoogle Scholar
  44. 44.
    Rigby PWJ, Diekmann M, Rhodes C, Berg P (1977) Labelling DNA to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol 113: 237–351PubMedCrossRefGoogle Scholar
  45. 45.
    Rosman NP, Pearce J (1967) The brain in multiple neurofibromatosis (von Recklinghausen’s disease). A suggested neuropathological basis for the associated mental defect. Brain 90: 829–837PubMedCrossRefGoogle Scholar
  46. 46.
    Rouleau GA, Wertelecki W, Haines JL, Hobbs WJ, Trofatter JA, Seizinger BR, Martuza RL, Superneau DW, Conneally PM, Gusella JF (1987) Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329: 246–248PubMedCrossRefGoogle Scholar
  47. 47.
    Saiki RK, Gyllensten UB, Erlich HA (1988) The polymerase chain reaction. In: Davies KE (ed) Genome analysis: a practical approach. IRL Press, Oxford, pp 141–152Google Scholar
  48. 48.
    Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463–5467PubMedCrossRefGoogle Scholar
  49. 49.
    Schwartz DC, Cantor CR (1984) Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis. Cell 37: 67–75PubMedCrossRefGoogle Scholar
  50. 50.
    Seizinger BR, Martuza RL, Gusella JF (1986) Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322: 644–646PubMedCrossRefGoogle Scholar
  51. 51.
    Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Faryniaz AG, Chao MV, Huson S, Kurl BR, Parry DM, Pericak-Vance MA, Collins FS, Hobbs WJ, Falcone BG, lannazzi JA, Roy JC, St George-Hyslop PH, Tanzi RE, Bothwell MA, Upadhyaya M, Harper P, Goldstein AE, Hoover DC (1987 a) Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell 49: 589–594PubMedCrossRefGoogle Scholar
  52. 52.
    Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, St George-Hyslop P, Huson S, Gusella JF, Martuza RL (1987 b) Common pathogenetic mechanism for three tumour types in bilateral acoustic neurofibromatosis. Science 236: 317–319PubMedCrossRefGoogle Scholar
  53. 53.
    Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE, Lamiell JM, Haines J, Yuen JWM, Collins D, Majoor-Krakauer D, Bonner T, Mathew C, Rubenstein A, Halperin J, McConkie-Rosell A, Green JS, Trofatter JA, Ponder BA, Eierman L, Bowmer MI, Schimke R, Oostra B, Aronin N, Smith DI, Drabkin H, Waziri MH, Hobbs WJ, Martuza RL, Conneally PM, Hsia YE, Gusella JF (1988) Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 32: 268–269CrossRefGoogle Scholar
  54. 54.
    Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavamee W, Vogelstein B (1992) Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355: 846–847PubMedCrossRefGoogle Scholar
  55. 55.
    Siggers DC, Boyer SH, Eldridge R (1975) Nerve growth factor in disseminated neurofibromatosis. N Engl J Med 292: 1134–1136PubMedGoogle Scholar
  56. 56.
    Sorensen SA, Mulvihill JJ, Nielsen A (1986) Long-term follow-up of von Recklinghausen neurofibromatosis: survival and malignant neoplasms. N Engl J Med 314: 1010–1015PubMedCrossRefGoogle Scholar
  57. 57.
    Southern EM (1975) Detection of specific sequences among DNA fragments separated by electrophoresis. J Mol Biol 98: 503–517PubMedCrossRefGoogle Scholar
  58. 58.
    Tory K, Brauch H, Linehan M (1989) Allele deletion analysis of tumours associated with von Hippel-Lindau disease ( VHL) identifies VHL as a tumour suppressor gene. Cytogenet Cell Genet 51: 1092CrossRefGoogle Scholar
  59. 59.
    Vile R (1989) Tumour suppressor genes. Brit Med J 298: 1335–1336PubMedCrossRefGoogle Scholar
  60. 60.
    Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins A, White R, O’Connell P (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62: 187–192PubMedCrossRefGoogle Scholar
  61. 61.
    Wallace MR, Marchuk DA, Andersen L, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FC (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF 1 patients. Science 249: 181–186PubMedCrossRefGoogle Scholar
  62. 62.
    Wertelecki W, Rouleau GA, Superneau DW, Forehand LW, Williams JP, Haines JL, Gusella JF (1988) Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. N Engl J Med 319: 278–283PubMedCrossRefGoogle Scholar
  63. 63.
    Weber JL, May PE (1989) Abundant class of human DNA polymorphism which can be typed using the polymerase chain reaction. Am J Hum Genet 44: 388–396PubMedGoogle Scholar
  64. 64.
    Wertelecki W, Rouleau GA, Superneau DW, Forehand LW, Williams JP, Haines JL, Gusella JF (1988) Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. N Engl J Med 319: 278–283PubMedCrossRefGoogle Scholar
  65. 65.
    Wong Z, Wilson V, Jeffreys AJ, Thein SL (1986) Cloning a selected fragment from a human DNA “fingerprint”: isolation of an extremely polymorphic minisatellite. Nucleic Acids Res 14: 4605–4616PubMedCrossRefGoogle Scholar
  66. 66.
    Young DF, Eldridge R, Gardner WJ (1970) Bilateral acoustic neuromas in a large kindred. J Am Med Ass 241: 347–353CrossRefGoogle Scholar
  67. 67.
    Xu G, O’Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, Weiss R (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599–608PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1993

Authors and Affiliations

  • A. E. Harding
    • 1
  1. 1.Institute of NeurologyLondonUK

Personalised recommendations